美国食品药品管理局考虑放宽肯尼迪小的未经证实的. FDA to consider easing restrictions on Kennedy Jr.'s unproven peptides.

联邦卫生官员将在7月举行会议, 以考虑放宽对罗伯特·肯尼迪小说推广的七种未经证实的类药物的限制. Federal health officials will hold a July meeting to consider easing restrictions on seven unproven peptides popularized by Robert F. Kennedy Jr. 这些常用于肌肉生长和抗衰老的物质缺乏强有力的科学证据, FDA也没有对其安全性进行评估. These substances, often marketed for muscle growth and anti-aging, lack robust scientific evidence and have not been evaluated for safety by the FDA. 批评者警告说, 这一举动破坏了该机构的药物批准标准, 并可能使公众接触到未经证实的潜在危险疗法. Critics warn the move undermines the agency's drug approval standards and could expose the public to unproven, potentially dangerous therapies.